This site uses cookies to bring you the best experience. Find out more
Skip to main content
↑

News

Find Out The Latest

Keep in touch with exciting developments from The Oxford Science Park and its occupiers here.

Contact us on comms@oxfordsp.com if you would like to know more about any of these stories.

You can also follow us on LinkedIn  

OMass Unveils Rich Drug Discovery Pipeline

OMass Unveils Rich Drug Discovery Pipeline

04 Nov 2021

OMass Unveils Rich Drug Discovery Pipeline Targeting Intractable or Inadequately Drugged Membrane and Complex-bound Proteins Oxford, United Kingdom – 4 November 2021 – OMass Therapeutics (‘OMass’ or ‘the Company’), a biotechnology company identifying medicines against highly validated target ecosystems, today unveiled its pipeline of five novel, differentiated small molecule drug programs, targeting intractable or inadequately drugged... Read more

Acquisition of ATDBio by Biotage AB to provide platform for further growth

Acquisition of ATDBio by Biotage AB to provide platform for further growth

20 Oct 2021

Acquisition of ATDBio by Biotage AB to provide platform for further growth Founders look forward to continued focus on customers and innovation Oxford and Southampton, UK, October 20 2021 – ATDBio, a leader in complex oligonucleotide synthesis, is pleased to announce that it has been acquired by the Swedish life sciences company Biotage AB1 for approximately £45m in cash and shares. The acquisition, which provides Biotage with expertise in... Read more

Scancell expands its R&D capabilities with new facilities at The Oxford Science Park

Scancell expands its R&D capabilities with new facilities at The Oxford Science Park

19 Oct 2021

Oxford, UK, 19 October 2021 – Scancell Holdings plc (AIM: SCLP), the developer of novel immunotherapies for the treatment of cancer and infectious disease, has expanded its R&D capabilities by taking new laboratory and office space in the Bellhouse Building at The Oxford Science Park (TOSP), one of the UK’s leading parks for science and technology companies. The new premises, which are complementary to Scancell’s laboratories in the Biodiscovery... Read more

Evox’ Exosome Engineering Approach for Surface Display of Biologics Highlighted

Evox’ Exosome Engineering Approach for Surface Display of Biologics Highlighted

07 Oct 2021

LANDMARK PAPER HIGHLIGHTS EVOX THERAPEUTICS’ CUTTING EDGE EXOSOME ENGINEERING APPROACH FOR ENHANCED SURFACE DISPLAY OF BIOLOGICS Evox’s engineered exosomes show better efficacy compared to conventional biologics and significantly outperformed other previously published exosome display platforms Evox Therapeutics Ltd (‘Evox’ or the ‘Company’), a leading exosome therapeutics company, announces that it has, in close collaboration with one of... Read more

Magdalen College & GIC enter Strategic Partnership to accelerate development of TOSP

Magdalen College & GIC enter Strategic Partnership to accelerate development of TOSP

05 Oct 2021

Magdalen College & GIC enter Strategic Partnership to accelerate development of The Oxford Science Park Investment initiates transformational construction programme as demand for life sciences & technology space continues Oxford, UK, October 5 2021 – Magdalen College Oxford, owner of The Oxford Science Park (TOSP), one of the UK’s leading parks for science and technology companies, and an affiliate of GIC have entered into a Strategic... Read more

The Daubeny Project

Imaginative design, inspiring spaces.

450,000 sq ft of
premium lab space
completing 2026

Discover More